 EMERYVILLE, Calif., Sept. 13, 2021 PRNewswire -- Dynavax Technologies Corporation Nasdaq: DVAX, a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Valneva SE has received a termination notice from the United Kingdom Government in relation to Valnevas supply agreement for its COVID-19 vaccine candidate, VLA2001. 